Fas/CD95/TNFRSF6 Protein (C-hFc, Human)

ALPS1A, APO-1, APT1, Apo-1 antigen, Apoptosis-mediating surface antigen FAS, CD95, FAS1, FASLG receptor, FASTM, TNFRSF6 and FAS, Tumor necrosis factor receptor superfamily member 6

Measured by its ability to inhibit Fas Ligand induced apoptosis of Jurkat human acute T cell leukemia cells. The ED50 for this effect is typically 0.02-0.1 μg/mL in the presence of 20 ng/mL recombinant human Fas ligand.